Complications of pelvic radiation in patients treated for gynecologic malignancies-Reference-Cited by-同舟云学术

Complications of pelvic radiation in patients treated for gynecologic malignancies

Published:2014-07-23 Issue:24 Volume:120 Page:3870-3883
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Viswanathan Akila N.¹,Lee Larissa J.¹,Eswara Jairam R.²,Horowitz Neil S.³,Konstantinopoulos Panagiotis A.⁴,Mirabeau-Beale Kristina L.⁵,Rose Brent S.⁵,von Keudell Arvind G.⁶,Wo Jennifer Y.⁷

Affiliation:

1. Department of Radiation Oncology; Brigham and Women's Hospital and Dana-Farber Cancer Institute; Boston Massachusetts

2. Division of Urology; Washington University School of Medicine; St. Louis Missouri

3. Division of Gynecologic Oncology; Brigham and Women's Hospital; Boston Massachusetts

4. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

5. Harvard Radiation Oncology Residency Program; Boston Massachusetts

6. Harvard Orthopedic Combined Residency Program; Boston Massachusetts

7. Department of Radiation Oncology; Massachusetts General Hospital; Boston Massachusetts

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28849/fullpdf

Reference114 articles.

1. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data;Nout;Eur J Cancer,2012

2. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study;Keys;Gynecol Oncol.,2004

3. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma;Creutzberg;Int J Radiat Oncol Biol Phys.,2011

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Value of Patient-Reported Outcomes to Predict Symptom Burden and Health-Related Quality of Life After Chemoradiation for Cervical Cancer: A Prospective Study;Practical Radiation Oncology;2024-09

2. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet;2024-09

3. Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology);La radiologia medica;2024-08-28

4. The Clinical Course of the Late Toxicity of Definitive Radiotherapy in Cervical Cancer;Medicina;2024-08-21

5. Impact of Vaginal Dilator Use and 68 Gy EQD2(α/β=3) Dose Constraint on Vaginal Complications in External Beam Irradiation Followed by Brachytherapy in Post-Operative Endometrial Cancer;Journal of Personalized Medicine;2024-08-08